About Vmars Biopharma Private Limited
Data last updated:
Vmars Biopharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 08 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72900KA2020PTC141983. Its GSTIN is 29AAHCV7785R1ZX (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sujith Naranthatta (Managing Director) and Mambully Premarajan Milash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #171/A 10th Main Laggere Main Road Peenya Industrial Area 3rd Phase, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.35 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹49.53 Lakh (net margin 4%) and EBITDA of ₹1.31 Cr (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 279% over three years.
The company has about 28 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VMARSBio. As per MCA filings, the company has open charges of ₹8.44 Cr on record.
For more details, the company can be reached via its website vmarsbio.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address#171/A 10th Main Laggere Main Road Peenya Industrial Area 3rd Phase, Bangalore, Karnataka, India – 560058
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vmars Biopharma Private Limited
The main business activity of Vmars Biopharma is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C10 | Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vmars Biopharma Private Limited FY 2025 filings available
Vmars Biopharma Private Limited reported revenue of ₹12.35 Cr (up 236% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vmars Biopharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 279% over three years, including 236% growth in the latest year. EBITDA rose 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vmars Biopharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹49.53 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vmars Biopharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vmars Biopharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vmars Biopharma Private Limited
Vmars Biopharma Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biopharma, Biotechnology, Electronic Equipment and Components Manufacturing). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hanuman Automation Private Limited | ₹12.42 Cr (FY 2020) | •••• | •••• | 18.0% | •••• | Bangalore, Karnataka, India |
| Nav Tech Electronics India Private Limited | ₹12.41 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Hyderabad, Telangana, India |
| Valient Biotech Private Limited | ₹12.39 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Satara, Maharashtra, India |
| Prymax Healthcare LLP | ₹12.38 Cr (FY 2021) | •••• | •••• | 3.0% | •••• | Faridabad, Haryana, India |
| Rapidradio Solutions Private Limited | ₹12.35 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Ahmedabad, Gujarat, India |
| Vmars Biopharma Private Limited this company | ₹12.35 Cr (FY 2025) | •••• | •••• | 236.0% | •••• | Bangalore, Karnataka, India |
| Salvonic Technologies Private Limited | ₹12.33 Cr (FY 2024) | •••• | •••• | 476.0% | •••• | New Delhi, Delhi, India |
| Grove Systems Private Limited | ₹12.31 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Pune, Maharashtra, India |
| Ozak Technologies Private Limited | ₹12.27 Cr (FY 2024) | •••• | •••• | 3377.0% | •••• | Ottapalam, Kerala, India |
| Cismac Automation Private Limited | ₹12.25 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Ahmedabad, Gujarat, India |
| Makimpact India Private Limited | ₹12.21 Cr (FY 2024) | •••• | •••• | 120.0% | •••• | Kochi, Kerala, India |
Peers are the five companies nearest above and the five nearest below Vmars Biopharma by revenue in the Biotechnology industry (Biopharma, Biotechnology, Electronic Equipment and Components Manufacturing), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vmars Biopharma Private Limited
Vmars Biopharma Private Limited is audited by DSKP & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DSKP & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vmars Biopharma Private Limited
Vmars Biopharma has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mambully Premarajan Milash Also directs: Estr Biosystems India Private Limited | Director | 02 Aug 2021 | 5 Years 2 Months | Current |
| Senthilkumar Annamuthu Murugesan | Director | 02 Aug 2021 | 5 Years 2 Months | Current |
| Sujith Naranthatta | Managing Director | 02 Aug 2021 | 5 Years 2 Months | Current |
| Santhekasalagere Thimmaiah Mahesha | Director | 02 Aug 2021 | 5 Years 2 Months | Current |
| Varuni Anant Ginigeri | Director | 28 Mar 2024 | 2 Years 6 Months | Current |
Ownership and Shareholding of Vmars Biopharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vmars Biopharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2025 | Others | ₹2 Cr | Open |
| 12 Dec 2025 | Others | ₹25.6 Lakh | Open |
| 11 Apr 2025 | Others | ₹13 Lakh | Open |
| 13 Mar 2025 | Others | ₹55.58 Lakh | Open |
| 23 Nov 2022 | Others | ₹5.5 Cr | Open |
Total charge records: 5 View all charges
Associated Brands with Vmars Biopharma Private Limited
Vmars Biopharma operates one associated brand: VMARSBio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Bioprocess engineering, product engineering, and process automation services in biotechnology. | vmarsbio.com |
Employees and EPFO Compliance at Vmars Biopharma Private Limited
Vmars Biopharma Private Limited has a workforce of 28 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vmars Biopharma Private Limited
Vmars Biopharma Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Varuni Anant Ginigeri was appointed as Director on 28 Mar 2024.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vmars Biopharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vmars Biopharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vmars Biopharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vmars Biopharma Private Limited
Vmars Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCV7785R1ZX | Karnataka | Active | 03 Apr 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vmars Biopharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vmars Biopharma Private Limited
Vmars Biopharma is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 08 December 2020 (6+ years old) and is registered under CIN U72900KA2020PTC141983.
Vmars Biopharma reported revenue of ₹12.35 Cr for FY 2025 (up 236% YoY).
Vmars Biopharma has 5 current directors:
- Sujith Naranthatta - Managing Director
- Mambully Premarajan Milash - Director
- Senthilkumar Annamuthu Murugesan - Director
- Santhekasalagere Thimmaiah Mahesha - Director
- Varuni Anant Ginigeri - Director
Vmars Biopharma reported a net profit of ₹49.53 Lakh (net margin 4%) and EBITDA of ₹1.31 Cr (EBITDA margin 10.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vmars Biopharma is 279% over three years. In the latest year (FY 2025) revenue rose 236%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vmars Biopharma is 29AAHCV7785R1ZX, registered in Karnataka.
The CIN (Corporate Identification Number) of Vmars Biopharma is U72900KA2020PTC141983. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vmars Biopharma was incorporated on 08 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Vmars Biopharma by revenue are Hanuman Automation Private Limited, Nav Tech Electronics India Private Limited, Valient Biotech Private Limited, Prymax Healthcare LLP, Rapidradio Solutions Private Limited and 5 more, all in the Biotechnology industry (Biopharma, Biotechnology, Electronic Equipment and Components Manufacturing).
Varuni Anant Ginigeri was appointed as Director on 28 Mar 2024. Aparna Asok ceased to be Director on 07 Jul 2022. Maheswari ceased to be Director on 07 Jul 2022. Vmars Biopharma has 8 board changes on record in total.
Vmars Biopharma can be reached through the website vmarsbio.com. Its registered office is in Bangalore, Karnataka, India.